MedTrace Logo

Evaluating the Occurrence of DKA in People With Type I Diabetes

NCT07739342 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-07-31

No results posted yet for this study

Summary

This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.

Conditions

Interventions

DEVICE

Abbott Continuous Dual Glucose Ketone Monitoring System

Participant will utilize the Abbott Continuous Dual Glucose Ketone Monitoring System in place of the Standard of Care

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara Alva, PhD · Abbott Diabetes Care Inc

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07739342 on ClinicalTrials.gov